| Website | criver.com |
| Category | BioTech |
| Phone | 781-222-6000 |
| Employees | |
| Founded | 1947 |
| Total | $36.4M |
| Accugenix, 8/12 | |
| Systems Pathology Company, 8/09 | $24M |
| Molecular Therapeutics, 9/08 | $12.4M |
| TOTAL | $34M |
| FUNDING TOTAL | $34M |
| Grant, 9/11 National Institutes of Health | $34M |
Charles River Laboratories International, Inc. provides solutions that accelerate the drug discovery and development process, including research models and associated services, and outsourced preclinical services. Segments The company has two segments: Research Models and Services (RMS) and Preclinical Services (PCS), which includes Phase I clinical services. RESEARCH MODELS AND SERVICES (RMS) The company supplies research models to the drug development industry. With approximately 150 different strains the company engages in the production and sale of research models, principally genetically and virally defined purpose-bred rats and mice. It also provides various related services that are designed to assist customers in supporting the use of research models in drug development. With multiple facilities located on three continents (North America, Europe and Asia (Japan)), the company maintains production centers, including a total of approximately 180 barrier rooms or isolator facilities located near its customers. RMS segment comprises Research Models, Research Model Services, and other related products and services
